Proteomic assay

DIAGNOSTIC_TEST2 trials

Sponsors

Dr Robert Docking, Maria Sklodowska-Curie National Research Institute of Oncology

Conditions

Acute Kidney InjuryClear Cell Renal Cell CarcinomaMalignant MelanomaTriple Negative Breast CancerUterine Cervical CancerUterine Corpus Cancer

Phase 2

Immune PET and Proteomics for the Assessment of Response to Spatially Fractionated or Palliative Radiotherapy With or Without Immunotherapy

Not yet recruitingNCT06976021

Maria Sklodowska-Curie National Research Institute of OncologyClear Cell Renal Cell Carcinoma, Malignant Melanoma, Triple Negative Breast Cancer +2

Start: 2025-06-30End: 2029-12-31Target: 60Updated: 2025-05-16

Unknown Phase

Evaluating Novel Biomarkers in Acute Kidney Injury

CompletedNCT01573104

Dr Robert DockingAcute Kidney Injury

Start: 2012-11-30End: 2015-01-31Updated: 2015-05-27